Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Ann Arbor, Michigan 48109


Purpose:

The primary purpose of this study is to compare the efficacy of adapalene (Differin®) gel 0.3% and tretinoin 0.05% emollient cream for the treatment of signs of photodamage, with tolerability assessment as a secondary objective.


Study summary:

Same as above.


Criteria:

Inclusion Criteria: - Male or Female aged 40 years of age and older with Fitzpatrick skin types I through III - Clinically moderate to severe photodamage Exclusion Criteria: - Subjects with history of laser resurfacing, dermabrasion, medium or deep chemical peel of the face - Subjects with diagnosis of skin cancer within 3 months of study entry - Subjects who have had superficial chemical peels, exfoliation or microdermabrasion of the face within 3 months of study entry - Subjects who have had botulinum toxin for facial rejuvenation within 6 months of study entry and are unwilling to refrain from botulinum toxin treatments during the study


NCT ID:

NCT00647556


Primary Contact:

Study Director
Ronald W Gottschalk, MD
Galderma Laboratories, L.P.


Backup Contact:

N/A


Location Contact:

Ann Arbor, Michigan 48109
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.